Nicolas Sommer

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with <i>BRAF</i> V600E Mutation

David S. Hong, Van K. Morris, Badi El Osta et al. · Cancer Discovery · 2016 · 218 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)

Herbert I. Hurwitz, Benjamin Tan, James A. Reeves et al. · The Oncologist · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502).

Frank A. Sinicrope, Fang‐Shu Ou, Tyler Zemla et al. · Journal of Clinical Oncology · 2019 · 63 citations

Medicine, Oncology, Pharmacology +17

Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial

Riad Salem, Daneng Li, Nicolas Sommer et al. · Cancer Medicine · 2021 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Overall survival in patients with glioblastoma before and after bevacizumab approval

Derek R. Johnson, Antonio Omuro, Arliene Ravelo et al. · Current Medical Research and Opinion · 2017 · 42 citations

Medicine, Oncology, Medical Oncology +15